Background Chronic diseases reduce the availability of iron for effective erythropoiesis. This
review summarises clinical consequences of iron deficiency (ID) and anaemia in cancer …

Inflammatory cytokines such as tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6),
among others, play a major role in the pathophysiology of anemia in the cancer patient not …

Anemia of chronic diseases is a condition that accompanies a specific underlying disease,
in which there is a decrease in hemoglobin, hematocrit and erythrocyte counts due to a …

Cancer-related anemia is a cytokine-mediated disorder resulting from complex interactions
between tumor cells and the immune system. Overexpression of certain inflammatory …

Objectives The aim of this paper is to review the pathogenesis and diagnostic approaches to
anemia in cancer patients. Methods PubMed was queried for various combinations of …

Anemia of cancer and chronic inflammatory diseases is a frequent complication affecting
quality of life. For cancer patients it represents a particularly bad prognostic. Low level of …

Chemotherapy-induced anemia (CIA) is a multifaceted entity influenced by a variety of
patient-and treatment-specific factors. Some sources of variation within CIA include …

Anaemia is a common complication in cancer patients. The decrease in haemoglobin is
associated with an impaired quality of life, poorer response to therapy and worse prognosis …

Cancer has a negative systemic impact on its host in addition to its local or metastatic effects,
and no cancer complication is more ubiquitous than anaemia, a condition for which there is …

Background: Targeting immune checkpoints represents an immense breakthrough in cancer
therapeutics. The prognostic value of hemoglobin (Hb) has been investigated in many …